Logo image of CLA.PA

CLARANOVA SE (CLA.PA) Stock Fundamental Analysis

Europe - EPA:CLA - FR0013426004 - Common Stock

1.828 EUR
+0.08 (+4.46%)
Last: 10/24/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CLA. CLA was compared to 111 industry peers in the Software industry. There are concerns on the financial health of CLA while its profitability can be described as average. CLA has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CLA has reported negative net income.
In the past year CLA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CLA reported negative net income in multiple years.
CLA had a positive operating cash flow in each of the past 5 years.
CLA.PA Yearly Net Income VS EBIT VS OCF VS FCFCLA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.14%, CLA is in line with its industry, outperforming 41.44% of the companies in the same industry.
CLA had an Average Return On Invested Capital over the past 3 years of 17.26%. This is above the industry average of 12.85%.
The 3 year average ROIC (17.26%) for CLA is well above the current ROIC(%ROIC%%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -1.14%
ROE N/A
ROIC N/A
ROA(3y)-4.27%
ROA(5y)-1.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.26%
ROIC(5y)13.84%
CLA.PA Yearly ROA, ROE, ROICCLA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

Looking at the Operating Margin, with a value of 8.86%, CLA is in the better half of the industry, outperforming 60.36% of the companies in the same industry.
In the last couple of years the Operating Margin of CLA has grown nicely.
CLA's Gross Margin of 29.19% is on the low side compared to the rest of the industry. CLA is outperformed by 80.18% of its industry peers.
CLA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.86%
PM (TTM) N/A
GM 29.19%
OM growth 3Y14.65%
OM growth 5Y11.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.23%
GM growth 5Y1.62%
CLA.PA Yearly Profit, Operating, Gross MarginsCLA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLA is creating value.
Compared to 1 year ago, CLA has more shares outstanding
CLA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CLA has been reduced compared to a year ago.
CLA.PA Yearly Shares OutstandingCLA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CLA.PA Yearly Total Debt VS Total AssetsCLA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of 0.63, we must say that CLA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.63, CLA is doing worse than 82.88% of the companies in the same industry.
CLA has a debt to FCF ratio of 5.38. This is a neutral value as CLA would need 5.38 years to pay back of all of its debts.
CLA has a Debt to FCF ratio (5.38) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.38
Altman-Z 0.63
ROIC/WACCN/A
WACC8%
CLA.PA Yearly LT Debt VS Equity VS FCFCLA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.50 indicates that CLA may have some problems paying its short term obligations.
CLA has a worse Current ratio (0.50) than 90.09% of its industry peers.
A Quick Ratio of 0.45 indicates that CLA may have some problems paying its short term obligations.
With a Quick ratio value of 0.45, CLA is not doing good in the industry: 90.99% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.5
Quick Ratio 0.45
CLA.PA Yearly Current Assets VS Current LiabilitesCLA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

3

3. Growth

3.1 Past

CLA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.81%, which is quite impressive.
CLA shows a decrease in Revenue. In the last year, the revenue decreased by -0.95%.
The Revenue has been growing by 13.58% on average over the past years. This is quite good.
EPS 1Y (TTM)34.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%497.85%
Revenue 1Y (TTM)-0.95%
Revenue growth 3Y1.74%
Revenue growth 5Y13.58%
Sales Q2Q%-2.36%

3.2 Future

CLA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.24% yearly.
Based on estimates for the next years, CLA will show a very negative growth in Revenue. The Revenue will decrease by -36.73% on average per year.
EPS Next Y74.55%
EPS Next 2Y26.49%
EPS Next 3Y28.24%
EPS Next 5YN/A
Revenue Next Year-76.76%
Revenue Next 2Y-51.07%
Revenue Next 3Y-36.73%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLA.PA Yearly Revenue VS EstimatesCLA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CLA.PA Yearly EPS VS EstimatesCLA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2

6

4. Valuation

4.1 Price/Earnings Ratio

CLA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 8.23, the valuation of CLA can be described as very reasonable.
96.40% of the companies in the same industry are more expensive than CLA, based on the Price/Forward Earnings ratio.
CLA is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 8.23
CLA.PA Price Earnings VS Forward Price EarningsCLA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLA indicates a rather cheap valuation: CLA is cheaper than 98.20% of the companies listed in the same industry.
99.10% of the companies in the same industry are more expensive than CLA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.47
EV/EBITDA 3.05
CLA.PA Per share dataCLA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

CLA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CLA's earnings are expected to grow with 28.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.49%
EPS Next 3Y28.24%

0

5. Dividend

5.1 Amount

CLA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLARANOVA SE

EPA:CLA (10/24/2025, 7:00:00 PM)

1.828

+0.08 (+4.46%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-13 2025-05-13
Earnings (Next)10-29 2025-10-29/amc
Inst Owners5.58%
Inst Owner ChangeN/A
Ins Owners5.02%
Ins Owner ChangeN/A
Market Cap104.58M
Revenue(TTM)488.60M
Net Income(TTM)-3300000
Analysts80
Price Target3.26 (78.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.25%
PT rev (3m)-7.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-7.69%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-76.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.23
P/S 0.21
P/FCF 3.47
P/OCF 2.83
P/B N/A
P/tB N/A
EV/EBITDA 3.05
EPS(TTM)-0.08
EYN/A
EPS(NY)0.22
Fwd EY12.16%
FCF(TTM)0.53
FCFY28.78%
OCF(TTM)0.64
OCFY35.28%
SpS8.54
BVpS-0.3
TBVpS-2.29
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.14%
ROE N/A
ROCE -2165%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 8.86%
PM (TTM) N/A
GM 29.19%
FCFM 6.16%
ROA(3y)-4.27%
ROA(5y)-1.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.26%
ROIC(5y)13.84%
ROICexc(3y)46.34%
ROICexc(5y)36.95%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)23.49%
ROCE(5y)18.83%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y3.39%
ROICexc growth 5Y10.18%
OM growth 3Y14.65%
OM growth 5Y11.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.23%
GM growth 5Y1.62%
F-Score7
Asset Turnover1.69
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.38
Debt/EBITDA 0.21
Cap/Depr 55.74%
Cap/Sales 1.39%
Interest Coverage 250
Cash Conversion 66.49%
Profit Quality N/A
Current Ratio 0.5
Quick Ratio 0.45
Altman-Z 0.63
F-Score7
WACC8%
ROIC/WACCN/A
Cap/Depr(3y)51.75%
Cap/Depr(5y)41.72%
Cap/Sales(3y)1.22%
Cap/Sales(5y)0.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%497.85%
EPS Next Y74.55%
EPS Next 2Y26.49%
EPS Next 3Y28.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.95%
Revenue growth 3Y1.74%
Revenue growth 5Y13.58%
Sales Q2Q%-2.36%
Revenue Next Year-76.76%
Revenue Next 2Y-51.07%
Revenue Next 3Y-36.73%
Revenue Next 5YN/A
EBIT growth 1Y22.32%
EBIT growth 3Y16.65%
EBIT growth 5Y26.75%
EBIT Next Year-30.02%
EBIT Next 3Y-5.72%
EBIT Next 5YN/A
FCF growth 1Y323.94%
FCF growth 3Y32.3%
FCF growth 5Y48.99%
OCF growth 1Y212.71%
OCF growth 3Y28.52%
OCF growth 5Y40.7%

CLARANOVA SE / CLA.PA FAQ

Can you provide the ChartMill fundamental rating for CLARANOVA SE?

ChartMill assigns a fundamental rating of 3 / 10 to CLA.PA.


What is the valuation status of CLARANOVA SE (CLA.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to CLARANOVA SE (CLA.PA). This can be considered as Fairly Valued.


How profitable is CLARANOVA SE (CLA.PA) stock?

CLARANOVA SE (CLA.PA) has a profitability rating of 4 / 10.


How financially healthy is CLARANOVA SE?

The financial health rating of CLARANOVA SE (CLA.PA) is 2 / 10.